Market Cap (In USD)
95.2 Thousand
Revenue (In USD)
-
Net Income (In USD)
-67.75
Avg. Volume
16.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-2.0E-4
- PE
- -
- EPS
- -
- Beta Value
- -1.601
- ISIN
- US83412T1043
- CUSIP
- -
- CIK
- 1165006
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. David J. Cutler
- Employee Count
- -
- Website
- https://www.solanbridgegroup.com
- Ipo Date
- 2007-06-29
- Details
- Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.
More Stocks
-
SEIT
-
GLANDGland Pharma Limited
GLAND
-
BBLRBubblr Inc.
BBLR
-
5870
-
RELINFRAReliance Infrastructure Limited
RELINFRA
-
CY4
-
8293
-
GOLF